In an adult with chronic rhinosinusitis without nasal polyps refractory to medical therapy and persistent nasal obstruction from enlarged inferior turbinates, should inferior turbinoplasty be added during functional endoscopic sinus surgery?

Adding Inferior Turbinoplasty to FESS for CRS Without Polyps

In adults with chronic rhinosinusitis without nasal polyps who have persistent nasal obstruction from enlarged inferior turbinates despite medical therapy, inferior turbinoplasty should be added to functional endoscopic sinus surgery when the turbinate hypertrophy is contributing significantly to nasal obstruction, as this provides additional symptomatic relief with minimal added morbidity.

Clinical Decision Framework

The 2025 AAO-HNS guidelines on surgical management of chronic rhinosinusitis 1 do not specifically address inferior turbinoplasty as an adjunct procedure. However, the guidelines emphasize that surgical planning should be based on symptoms, disease characteristics, and quality of life rather than arbitrary imaging criteria 1. This principle extends to concurrent procedures addressing anatomic contributors to nasal obstruction.

When to Add Turbinoplasty

Add inferior turbinoplasty when:

• Physical examination demonstrates significant inferior turbinate hypertrophy (not just mucosal edema)
• The patient reports persistent nasal obstruction as a primary symptom
• The turbinate enlargement is structural (bony or soft tissue) rather than purely inflammatory/reversible
• The hypertrophy is contributing to the overall nasal airway obstruction beyond the sinus disease alone

Evidence Supporting Concurrent Turbinoplasty

A 2025 systematic review 2 examining FESS with versus without inferior turbinoplasty found:

• Quality of life improved with both approaches, but routine addition of turbinoplasty did not consistently enhance overall outcomes
• Select subgroups may benefit, particularly patients with nasal polyps
• The procedure appears safe with minimal added morbidity
• One pediatric study showed no increased 30-day readmission risk

The key finding is that while turbinoplasty doesn't universally improve outcomes when added routinely, it provides benefit in appropriately selected patients with documented turbinate hypertrophy contributing to obstruction.

Technical Considerations

Endoscopic turbinoplasty is preferred over conventional partial turbinectomy 3:

• Better immediate postoperative symptom relief (days 7-15)
• Lower postoperative morbidity in the early period
• Comparable long-term outcomes at 3 months
• Preservation of mucosal function and vasoreactivity 4

The microdebrider-assisted endoscopic approach achieved 93% improvement in nasal patency with minimal complications (synechiae in 12%, nearly all resolved) 4. Importantly, postoperative rhinomanometry demonstrated retained vasoactive capability of the preserved mucosa 4.

Critical Pitfalls to Avoid

Do not perform aggressive turbinectomy:

• Submucosal preservation techniques are essential 5
• Aggressive resection increases risk of empty nose syndrome
• Preserve mucosa, cilia, and thermoreceptors for long-term function 5

Do not add turbinoplasty based solely on CT findings:

• The 2025 guidelines explicitly state not to plan surgery "solely based on arbitrary criteria regarding mucosal thickening" 1
• Clinical examination and symptom correlation are paramount
• Turbinate size on imaging may not correlate with functional obstruction

Practical Algorithm

1. Verify turbinate contribution to obstruction:

   • Perform nasal endoscopy to assess turbinate size and position
   • Apply topical decongestant to differentiate structural from mucosal hypertrophy
   • If turbinates shrink significantly with decongestant, medical management may suffice

2. If structural hypertrophy confirmed:

   • Add endoscopic turbinoplasty using submucosal preservation technique
   • Use microdebrider or radiofrequency ablation rather than aggressive resection
   • Target the anterior/middle portions where obstruction is typically greatest

3. Patient counseling:

   • Explain that turbinoplasty addresses the anatomic obstruction component
   • Set expectations that CRS may still require long-term medical management 1
   • Discuss that early postoperative improvement may be more noticeable with turbinoplasty 3

Nuance in CRS Without Polyps

The systematic review 2 noted potential benefit in patients with nasal polyps, but your question specifically addresses CRS without polyps. In this population, the decision hinges more heavily on the mechanical contribution of turbinate hypertrophy to obstruction rather than inflammatory disease burden. The absence of polyps may actually make turbinate hypertrophy a more prominent contributor to symptoms, strengthening the case for concurrent turbinoplasty when documented on examination.